Hogan Lovells 2024 Election Impact and Congressional Outlook Report
Dr. Andreas von Falck
Partner Intellectual Property
Languages
English, Italian, French, German
-
Overview
-
Experience
-
Credentials
-
Insights and events
Legal 500, 2018Hogan Lovells International LLP’s ‘first-class’ patent team shows ‘excellent quality’ and ‘promptness’, particularly in the coordination of complex cross-border disputes, most notably in the pharmaceuticals and telecoms sectors.
Andreas von Falck is a trial lawyer with a track record for developing successful litigation strategies. He loves technology and science and finding ways to convey simple messages to the decision makers. In its 2019 edition, IAM wrote about him: “a defining individual in the world of German intellectual property” who’s “advocacy can flip the outcome of a case, which is precisely why he is so sought after.”
Andreas von Falck is part of our global Patent Litigation practice. He has an excellent track record in litigating patents in all areas of patent law but with a particular focus on the life sciences, chemical, and high-tech industries. Andreas has advised many of the world's leading companies in patent litigation in Germany and has had conduct of a vast number of cross border proceedings including all parts of Europe. In addition, he has had a number of remarkable wins in validity appeals before the German Federal Supreme Court.
As part of our multiple award winning global patent litigation practice, Andreas is recommended for patent litigation by Chambers Global World's Leading Lawyers, Who's Who Legal, Managing Intellectual Property, Legal 500, and JUVE, the leading German legal directory. Recognised for offering first class, innovative solutions, He is praised for his "analytical approach and availability" (Chambers 2018) and as "extremely knowledgeable and one of the top litigators in Germany, if not the top."(Chambers 2017)
Legal 500, 2018Hogan Lovells International LLP’s ‘first-class’ patent team shows ‘excellent quality’ and ‘promptness’, particularly in the coordination of complex cross-border disputes, most notably in the pharmaceuticals and telecoms sectors.
Representative experience
Working for many of the world's largest companies in the life sciences and chemical industries and arguing for high tech companies in FRAND disputes.
Representing a leading US pharma company in patent nullity and infringement proceedings up to the Federal Supreme Court regarding its world leading antidepressant.
Acting for a US medical devices manufacturer in European litigation and coordinating Asian and US litigation regarding neurovascular implants.
Acting for a world leading pharmaceutical and biotech company regarding several of its blockbuster biotech products.
Acting for leading chemical company in patent litigation with competitor in Germany and the EPO.
Acting for a leading US drug manufacturer in European Court of Justice regarding supplementary protection certificate.
Acting for a leading global handset manufacturer on all aspects of defending against one of the world's largest non-practicing entities.
Representing a Japanese high-tech company against "troll" a attack.
Advising a world leading industrial on its worldwide patent strategy and implementation.
Advising a diagnostics company on patenting strategy.
Assisting a top-ten pharma company on obtaining and defending secondary protection for new indications of its anti-cancer medicament.
Credentials
Education
- Dr. iur., University of Freiburg, 1997
- University of Geneva
- University of Tuebingen
Court admissions
- Unified Patent Court
- Germany
Recognition
Events
Hogan Lovells Events
7 March 2024 | 15:00 p.m. - 16:30 p.m. (JST)
Webinar
24 May 2022 | 3:00 PM - 4:30 PM (JST)
Hogan Lovells Events
Tuesday, June 15, 2021; 10:00 a.m. - 11:15 a.m. EDT; 2:00 p.m. - 3:15 p.m. GMT; 4:00 p.m. - 5:15 p.m. CEST